Dapagliflozin metformin er?

Dapagliflozin metformin ER is a fixed-dose combination medicine used to help control blood sugar in adults with type 2 diabetes. It combines:
- Dapagliflozin (an SGLT2 inhibitor) which lowers blood glucose by causing the kidneys to excrete more glucose in the urine.
- Metformin extended-release (ER) which lowers glucose production in the liver and improves insulin sensitivity.

Key points:
- Brand example: This combination is sold as Xigduo XR in many places.
- How it’s used: It’s taken by mouth, usually once daily with the evening meal. Do not crush or chew the extended-release tablet; swallow whole.
- Who should not use it or needs caution: People with significantly impaired kidney function (eGFR very low) or other conditions that affect metformin use should not start or may need dose adjustments. It’s not for type 1 diabetes or diabetic ketoacidosis. Always follow your clinician’s dosing and safety guidance.
- Common side effects: Increased urination, genital yeast infections, urinary tract infections, nausea or diarrhea. There’s a rare risk of lactic acidosis with metformin and other serious but uncommon risks with SGLT2 inhibitors (e.g., ketoacidosis, Fournier’s gangrene). Dehydration can occur, especially if you’re not drinking enough fluids.
- Important safety notes: Because this is a fixed-dose combination, you’ll follow the dosing prescribed by your doctor, and you’ll need monitoring of kidney function and other parameters as advised.

If you’d like, I can tailor the info to your country’s approved labeling, or explain dosing, side effects, or interactions in more detail. Also tell me if you’d prefer this in Indonesian.